Kawasaki disease

Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

Retrieved on: 
Monday, March 4, 2024
Kawasaki disease, Birth, Headache, Doctor of Philosophy, Radiology, Aes, Combat, MD, Myocardial perfusion imaging, FDA, Food, Dizziness, Cardiology, Shanda, Heart rate, Nausea, LNTH, Safety, Fatigue, Kawasaki, Golding, Patient, Heart, All, Diagnosis, Male, Movement

This approval represents a significant step forward in pediatric medicine, providing healthcare professionals with a valuable tool to opacify the left ventricular chamber and better identify the left ventricular endocardial border.

Key Points: 
  • This approval represents a significant step forward in pediatric medicine, providing healthcare professionals with a valuable tool to opacify the left ventricular chamber and better identify the left ventricular endocardial border.
  • Currently, DEFINITY is the most utilized, extensively studied, and a trusted diagnostic ultrasound enhancing agent in the U.S.1-3
    “The expanded indication for DEFINITY is a testament to the rigorous research and development efforts undertaken by Lantheus to address unmet medical needs of pediatric patients,” said Jean-Claude Provost, MD, Chief Medical Officer.
  • “We are proud that this approval will extend the benefits of DEFINITY to healthcare professionals who work with these young individuals.”
    Clinical studies have substantiated the efficacy and safety of DEFINITY in pediatric patients.
  • The Kutty and Fine studies each reported successful left ventricular opacification in all participants.

Octane and Kawasaki Announce Strategic Agreement

Retrieved on: 
Tuesday, January 23, 2024
Entrepreneurship, Fintech, Kawasaki disease, JET, Dealer, ATV, Motorcycle, Gasoline

NEW YORK, Jan. 23, 2024 /PRNewswire/ -- Octane® (Octane Lending, Inc.®), the fintech revolutionizing the buying experience for major recreational purchases, and Kawasaki Motors Corp., U.S.A., (Kawasaki) announced a new agreement to provide promotional financing for prime customers in the United States. 

Key Points: 
  • Kawasaki Dealers to Benefit from Octane's Fast, Easy Experience and Full-Spectrum Financing
    NEW YORK, Jan. 23, 2024 /PRNewswire/ -- Octane ® (Octane Lending, Inc.®), the fintech revolutionizing the buying experience for major recreational purchases, and Kawasaki Motors Corp ., U.S.A., (Kawasaki) announced a new agreement to provide promotional financing for prime customers in the United States.
  • "We're thrilled to strengthen our longstanding relationship with Kawasaki and become its first full-spectrum credit partner," said Mark Davidson, Co-Founder and Chief Revenue Officer at Octane.
  • "Octane has proven to be a great fit for Kawasaki and our customers," said Kawasaki Senior Director of US Sales, Anthony Kestler.
  • "With full spectrum lending, Kawasaki dealers now have multiple options for financing customers on all Kawasaki powersports products, accessories and apparel.

Massachusetts General Hospital Researchers and Prevencio Announce the Power of Artificial Intelligence HART® Platform for Medical Diagnostic Test Development

Retrieved on: 
Monday, July 24, 2023
Cardiology, General Health, Health, Artificial Intelligence, Medical Devices, Technology, Other Technology, Other Health, Anaheim Convention Center, Obesity, MGH, Heart failure, Chronic kidney disease, Diabetes, Kawasaki, Kawasaki disease, Moyamoya disease, Stroke, Cardiovascular disease, Harvard Medical School, Hypertension, MD, Patient, Risk, Artificial intelligence, Hospital, Research institute, AI, Principal, Massachusetts General Hospital, HART, Medical device, Medicine

The HART platform is disease agnostic and may be used to develop diagnostics beyond cardiac disease.

Key Points: 
  • The HART platform is disease agnostic and may be used to develop diagnostics beyond cardiac disease.
  • Prevencio’s two lead tests, HART CVE and HART CADhs, are currently available to medical professionals for patient use.
  • Researchers from Massachusetts General Hospital (MGH) tested more than 1,250 patients undergoing coronary or peripheral angiography to collaborate in the development and validation of the AI-driven HART platform which has produced seven highly accurate, algorithmic multiple protein blood tests.
  • “With the rapid rise in cardiovascular disease, better tools to recognize risk and intervene proactively are needed.

Electric Scooters to Continue Skyrocketing in Popularity, Reports IDTechEx

Retrieved on: 
Thursday, April 6, 2023
Electric two-wheeler sharing, Travel, Motorcycle, ICE, Kawasaki, Forecasting, Energica Motor Company, Microcar, Head, Kawasaki disease, Growth, City, OEM, VinFast, Family, NIU, Renewable energy, Electric motor, Pega

The market for electric scooters and motorcycles is booming outside of China as more countries are looking to shift away from ICE counterparts.

Key Points: 
  • The market for electric scooters and motorcycles is booming outside of China as more countries are looking to shift away from ICE counterparts.
  • IDTechEx expects growing markets like Vietnam and India to take up larger market shares in the coming years as Chinese sales decline.
  • In 2022, about 470,000 electric two-wheelers (mainly low-power e-scooters) were sold, with IDTechEx forecasting sales to cross over 9 million units by 2043.
  • The IDTechEx report covers the regions mentioned above in more detail and EU+UK and US markets for electric two-wheelers.

Electric Scooters to Continue Skyrocketing in Popularity, Reports IDTechEx

Retrieved on: 
Thursday, April 6, 2023
Electric two-wheeler sharing, Travel, Motorcycle, ICE, Kawasaki, Forecasting, Energica Motor Company, Microcar, Head, Kawasaki disease, Growth, City, OEM, VinFast, Family, NIU, Renewable energy, Electric motor, Pega

The market for electric scooters and motorcycles is booming outside of China as more countries are looking to shift away from ICE counterparts.

Key Points: 
  • The market for electric scooters and motorcycles is booming outside of China as more countries are looking to shift away from ICE counterparts.
  • IDTechEx expects growing markets like Vietnam and India to take up larger market shares in the coming years as Chinese sales decline.
  • In 2022, about 470,000 electric two-wheelers (mainly low-power e-scooters) were sold, with IDTechEx forecasting sales to cross over 9 million units by 2043.
  • The IDTechEx report covers the regions mentioned above in more detail and EU+UK and US markets for electric two-wheelers.

Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease

Retrieved on: 
Wednesday, March 15, 2023
Research, Nobel Prize in Chemistry, Machine learning, Society, Regeneron Science Talent Search, Trustee, Climate change, Risk, Physics, Injury, Software, School, Cell, Creativity, Traumatic brain injury, Brain damage, Semantics, Calculus, Sidhu, Algorithm, Human, National Medal, Student, Nobel Prize, Diagnosis, Society for Science, Science News, Weather, Language, Thought, Suicide, Kawasaki disease, RNA, Intelligence, Culture, Stroke, Caterpillar, Traffic barrier, ARD International Music Competition, Pharmaceutical industry, Birth control, Management, STEM, Chemistry, Regeneron Pharmaceuticals, T3, Science

The competition, now in its 82nd year, celebrates and rewards young scientists focused on a wide range of scientific topics.

Key Points: 
  • The competition, now in its 82nd year, celebrates and rewards young scientists focused on a wide range of scientific topics.
  • “Congratulations to the winners of the Regeneron Science Talent Search 2023,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News.
  • “My experiences participating in the Science Talent Search changed my life, helping convince me to devote my life to trying to use science to cure disease.
  • In total, Regeneron awarded $3.1 million in prizes this year, including $2,000 to each of the top scholars and their schools.

Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease

Retrieved on: 
Wednesday, March 15, 2023
Research, Nobel Prize in Chemistry, Machine learning, Society, Regeneron Science Talent Search, Trustee, Climate change, Risk, Injury, Physics, Software, School, Cell, Creativity, Traumatic brain injury, Brain damage, Semantics, Patient, Calculus, Sidhu, Algorithm, Human, National Medal, Student, Nobel Prize, Diagnosis, Society for Science, Science News, Weather, Language, Thought, Suicide, Kawasaki disease, RNA, Intelligence, Culture, Stroke, Caterpillar, Traffic barrier, ARD International Music Competition, Pharmaceutical industry, Birth control, Management, STEM, Chemistry, Regeneron Pharmaceuticals, T3, Science

TARRYTOWN, N.Y. and WASHINGTON, March 14, 2023 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Neel Moudgal, 17, of Saline, Mich., won the top $250,000 award in the 2023 Regeneron Science Talent Search, the nation's oldest and most prestigious science and math competition for high school seniors.

Key Points: 
  • The competition, now in its 82nd year, celebrates and rewards young scientists focused on a wide range of scientific topics.
  • "Congratulations to the winners of the Regeneron Science Talent Search 2023," said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News.
  • The Regeneron Science Talent Search empowers young people who are passionate about innovation and using scientific discovery to contribute to improving our world.
  • In total, Regeneron awarded $3.1 million in prizes this year, including $2,000 to each of the top scholars and their schools.

Prevencio Announces National Medicare Pricing for Company’s Three AI-Powered HART® Cardiac Blood Tests

Retrieved on: 
Tuesday, January 10, 2023
Technology, Medical Devices, Medical Supplies, Hospitals, Health Technology, Cardiology, Software, Health, Artificial Intelligence, Arrest, Cardiovascular disease, Cancer, Child, HART, Public health, CMS, Death, Centers for Medicare & Medicaid Services, Risk, CPT, Medicare, Kawasaki, Patient, Kawasaki disease, Stroke, Hospital, Pharmaceutical industry, Medicaid

Prevencio, Inc. , The AI-Powered Cardiac Blood Test Company, today announced the Centers for Medicare & Medicaid Services (CMS) has set a National Medicare payment rate of $390.75 for each of the Company’s three lead proprietary HART® cardiac blood tests.

Key Points: 
  • Prevencio, Inc. , The AI-Powered Cardiac Blood Test Company, today announced the Centers for Medicare & Medicaid Services (CMS) has set a National Medicare payment rate of $390.75 for each of the Company’s three lead proprietary HART® cardiac blood tests.
  • The payment rates went into effect January 1, 2023, for Current Procedural Terminology (CPT) billing codes 0308U (for CADhs), 0309U (for HART CVE), and 0310U (for HART KD).
  • HART KD is the only available test to diagnose whether a child has Kawasaki disease.
  • In the U.S., it is the leading cause of death and kills more people than all cancers combined.

KAWASAKI KEYS IN ON NEW DEALER PROSPECTS AS IT RETURNS TO AIMEXPO 2023

Retrieved on: 
Wednesday, November 30, 2022
Statistics, Motorcycle, Kawasaki, Internet, Engineering, Multimedia, Insurance, JET, ATV, Government, MIC, B2B, Las Vegas Convention Center, Kawasaki disease, Russian, Motorcycle Industry Council, Research, Consultant, Iron

"Weare excitedto haveKawasakijoinus for AIMExpo 2023," saidCinnamon Kernes, vice president ofmarket expansion.

Key Points: 
  • "Weare excitedto haveKawasakijoinus for AIMExpo 2023," saidCinnamon Kernes, vice president ofmarket expansion.
  • "Kawasaki, one of the earliest members of the Motorcycle Industry Counciland a long-time industry leader, hasalways beenat the forefrontof powersports trends and innovation.
  • In the future, Kawasaki Motors, Ltd. is committed to maintaining and furthering these strengths which will surely give birth to new legends.
  • Information about Kawasaki's complete line of powersports products and Kawasaki affiliates can be found on the Internet at www.kawasaki.co
    View original content to download multimedia: https://www.prnewswire.com/news-releases/kawasaki-keys-in-on-new-dealer-...

KAWASAKI ENGINES TO DEBUT NEW LINE OF ENGINES AT EQUIP EXPOSITION 2022

Retrieved on: 
Thursday, October 13, 2022
Zero-turn mower, Growth, Hand, Kentucky Exposition Center, Engine, Kawasaki, Original equipment manufacturer, Feeding America, Multimedia, Partnership, Technology, Kawasaki disease, Industry, Hunger, View, Online shopping, Iron, Nightclub, Pacific Ocean

GRAND RAPIDS, Mich., Oct. 13, 2022 /PRNewswire/ -- Kawasaki Engines will pack additional horsepower for Equip Exposition 2022, highlighted by the launch of a new engine line that will join the Kawasaki lineup. In tandem with the new engine offerings, the company will present an indoor and outdoor experience that underscores the quality, value and reliability Kawasaki delivers to outdoor lawn equipment manufacturers, dealers and end users.

Key Points: 
  • GRAND RAPIDS, Mich., Oct.13, 2022 /PRNewswire/ -- Kawasaki Engines will pack additional horsepower for Equip Exposition 2022, highlighted by the launch of a new engine line that will join the Kawasaki lineup.
  • During the Oct. 19-21 gathering at the Kentucky Exposition Center in Louisville, Kawasaki Engines' indoor exhibit space [booth #1064] will focus on the customer journey, where Kawasaki's engines, parts, and accessories work together to deliver proven performance and quality.
  • The third station will provide attendees an in-depth look at Kawasaki Engines' line of fuels: KTECH Pre-Mixed 2-Cycle Fuel + Oil and KTECH Ethanol-Free 4-Cycle Fuel.
  • Kawasaki Engines, a division of Kawasaki Motors Corp., U.S.A., distributes gasoline engines for landscape, industrial, and consumer markets.